Northern Trust’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.58M | Buy |
232,016
+49,717
| +27% | +$554K | ﹤0.01% | 2842 |
|
|
2025
Q1 | $2.24M | Sell |
182,299
-2,548
| -1% | -$31.3K | ﹤0.01% | 2859 |
|
|
2024
Q4 | $2.07M | Buy |
184,847
+25,035
| +16% | +$280K | ﹤0.01% | 3006 |
|
|
2024
Q3 | $1.11M | Buy |
159,812
+117,647
| +279% | +$820K | ﹤0.01% | 3315 |
|
|
2024
Q2 | $319K | Buy |
42,165
+12,571
| +42% | +$95K | ﹤0.01% | 3673 |
|
|
2024
Q1 | $391K | Sell |
29,594
-5,428
| -15% | -$71.7K | ﹤0.01% | 3645 |
|
|
2023
Q4 | $361K | Buy |
35,022
+12,821
| +58% | +$132K | ﹤0.01% | 3661 |
|
|
2023
Q3 | $216K | Buy |
22,201
+6,095
| +38% | +$59.3K | ﹤0.01% | 3783 |
|
|
2023
Q2 | $72.3K | Sell |
16,106
-65
| -0.4% | -$292 | ﹤0.01% | 4125 |
|
|
2023
Q1 | $75K | Hold |
16,171
| – | – | ﹤0.01% | 4154 |
|
|
2022
Q4 | $24.1K | Hold |
16,171
| – | – | ﹤0.01% | 4451 |
|
|
2022
Q3 | $61K | Buy |
16,171
+4,896
| +43% | +$18.5K | ﹤0.01% | 4271 |
|
|
2022
Q2 | $56K | Sell |
11,275
-48,909
| -81% | -$243K | ﹤0.01% | 4375 |
|
|
2022
Q1 | $494K | Sell |
60,184
-4,343
| -7% | -$35.6K | ﹤0.01% | 3747 |
|
|
2021
Q4 | $650K | Sell |
64,527
-852
| -1% | -$8.58K | ﹤0.01% | 3711 |
|
|
2021
Q3 | $1.04M | Sell |
65,379
-5,898
| -8% | -$93.5K | ﹤0.01% | 3541 |
|
|
2021
Q2 | $1.7M | Buy |
+71,277
| New | +$1.7M | ﹤0.01% | 3399 |
|